Business Parks & Science Centres



Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 62 63 64 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Addex Therapeutics S.A.. (1/29/13). "Press Release: Addex Dipraglurant Reduces Motor Abnormalities in a Preclinical Model Relevant for Several Rare Types of Dystonia". Geneva. 2013-01-29
AiCuris GmbH & Co. KG. (1/29/13). "Press Release: AiCuris Surpasses 50% Enrollment Milestone in Phase II Superiority Trial for Herpes Drug Pritelivir". Wuppertal. 2013-01-29
Barmer GEK. (1/29/13). "Pressemitteilung: Barmer GEK Arztreport 2013. ADHS-Diagnosen und Ritalin-Verordnungen boomen". Berlin. 2013-01-29
BASF SE. (1/29/13). "Press Release: BASF to Expand Its Plant Biotechnology Research into Fungal Resistance in Corn". Research Triangle Park, NC. 2013-01-29
Zytoprotec GmbH. (1/29/13). "Press Release: Zytoprotec Raises EUR 2 Million in Financing from Baxter Ventures". Vienna. 2013-01-29
High-Tech Gründerfonds Management GmbH. (1/28/13). "Press Release: HTGF, BayernKapital and a Business Angel Consortium Invest in Advanova GmbH". Bonn, Landshut & Erlangen. 2013-01-28
Epigenomics AG. (1/25/13). "Press Release: Epigenomics AG Successfully Completes Capital Increase [Not for distribution in the United States]". Berlin & Seattle, WA. 2013-01-25
Lead Discovery Center GmbH. (1/25/13). "Press Release: LDC Forms Drug Discovery Alliance with AstraZeneca". Dortmund. 2013-01-25
Biognosys AG. (1/23/13). "Press Release: Biognosys Announces Spectronaut Software Launch". Zürich-Schlieren. 2013-01-23
Merck Serono. (1/23/13). "Press Release: Merck Serono Announces the Creation of Ondaco, the Fifth Company Stemming From Its Entrepreneur Partnership Program". Geneva. 2013-01-23
Apoplex Medical Technologies GmbH. (1/23/13). "Pressemitteilung: Gut für Herz und Hirn – Kooperation entlastet Klinikpersonal und Schlaganfallpatienten. Dräger und Apoplex Medical Technologies kombinieren Technologien". Pirmasens. 2013-01-23
Bayer AG. (1/23/13). "Press Release: Dr. Jörg Reinhardt to Leave Bayer HealthCare". Leverkusen. 2013-01-23
BMBF. (1/23/13). "Pressemitteilung: Die Vermessung der Pflanze. Deutsches Pflanzen-Phänotypisierungs-Netzwerk geht an den Start – Rachel: »Erträge von Nutzpflanzen müssen gesteigert werden". 2013-01-23
Cytos Biotechnology AG. (1/23/13). "Press Release: Cytos to Regain Rights to Smoking Cessation Vaccine". Schlieren. 2013-01-23
Addex Therapeutics S.A.. (1/22/13). "Press Release: Addex Announces Issuance of a Broad US Composition of Matter Patent for ADX71441". Geneva. 2013-01-22
Lophius Biosciences GmbH. (1/22/13). "Press Release: Lophius Biosciences Closes Financing Round and Expands Management Board. Financing Round Closed with Volume of about 4 Mio. EUR". Regensburg. 2013-01-22
Deutsche Metrohm GmbH & Co. KG. (1/22/13). "Pressemitteilung: Neue Geschäftsleitungen bei Methrom Deutschland". 2013-01-22
Biotest AG. (1/22/13). "Press Release: Ad hoc. Biotest AG – Increase in Earnings after Tax for Fiscal Year 2012". Dreieich. 2013-01-22
Novartis AG. (1/22/13). "Press Release: Novartis Receives EU Approval for Bexsero, First Vaccine to Prevent the Leading Cause of Life-threatening Meningitits across Europe". Basel. 2013-01-22
BioRegio STERN Management GmbH. (1/21/13). "Pressemitteilung: Reduktion von Tierversuchen durch neue in vivo-Biomaterialtests. NMI entwickelt Mikrosensorimplantat zur Überwachung implantierbarer Biomaterialien". 2013-01-21
Biotest AG. (1/21/13). "Press Release: Biotest AG with New Sales and Distribution Activities in Russia and Greece". Dreieich. 2013-01-21
Centre for Drug Research and Development, The (CDRD). (1/21/13). "Press Release: Alliance of Translational Research Centres Established to Accelerate Global Drug Development". London & Vancouver, BC. 2013-01-21
Schott North America. (1/21/13). "Press Release: Schott and Applied Microarrays Establish Distribution Partnership for Nexterion Products in the US and Canada". Elmsford, NY & Tempe, AZ. 2013-01-21
ETH Zürich. (1/21/13). "Pressemitteilung: Exakte Karte für das Hefe-Proteom". 2013-01-21
Bayer AG. (1/21/13). "Press Release: Further Milestone Towards Building a Leading Biologics Technology Platform. Bayer CropScience Completes Acquisition of Prophyta GmbH". Monheim. 2013-01-21
Ayoxxa Biosystems GmbH. (1/21/13). "Press Release: Ayoxxa Biosystems Announces Signing of a Research Collaboration Agreement with the National University of Singapore as well as a Second Closing of the Series A Financing Round". Singapore & Cologne. 2013-01-21
Apeptico Forschung und Entwicklung GmbH. (1/18/13). "Press Release: Apeptico Granted Orphan Drug Designation by EMA and FDA for Development Compound AP301 for Treatment of High Altitude Pulmonary Oedema". Vienna. 2013-01-18
Bruker Corporation. (1/18/13). "Press Release: Bruker Wins Order from Former IUCr President. D8 Venture SC-XRD System for Charge Density and Protein Structure Investigations". 2013-01-18
BioRegio STERN Management GmbH. (1/17/13). "Pressemitteilung: »Wir machen Unsichtbares sichtbar«. Tübinger Start-up hat sich auf die genomische Analyse von Saatgut spezialisiert". 2013-01-17
Biotest AG. (1/16/13). "Press Release: Biotest Announces Strategic Long-term Manufacturing, Supply and License Agreement". Dreieich & Baco Raton, FL. 2013-01-16
Markes International Ltd.. (1/16/13). "Press Release: Business as Usual for Markes International as Schauenburg International Acquires a Majority Share". Llantrisant. 2013-01-16
Paladin Labs, Inc.. (1/16/13). "Press Release: Paladin Labs Signs Agreement for Novel Biologic to Treat Neuroblastoma". Montréal, QC. 2013-01-16
Almsco International. (1/16/13). "Press Release: Almsco at Pittcon 2013. Cutting-edge Mass Spectrometry Technology on Show at Pittcon 2013". 2013-01-16
BB Biotech AG. (1/16/13). "Press Release: BB Biotech AG Earns After-tax Profits of CHF 368 Million in Fiscal 2012". 2013-01-16
Cytos Biotechnology AG. (1/16/13). "Press Release: Cytos Provides Update of Phase 2b Clinical Trial of CYT003 in Allergic Asthma. Guidance for Top-line Results in 1H 2014 Reiterated". Schlieren. 2013-01-16
Biocartis S.A.. (1/15/13). "Press Release: Biocartis Strengthens Management Team with General Counsel". Lausanne & Mechelen. 2013-01-15
IBB Netzwerk GmbH. (1/15/13). "Press Release: Launch of New Website Completes Change of Name of Industrielle Biotechnologie Bayern Netzwerk GmbH". Martinsried. 2013-01-15
Omnilab-Laborzentrum GmbH & Co. KG. (1/15/13). "Pressemitteilung: Omnilab und Bruker gehen gemeinsame Vertriebswege. Mit Beginn 2013 neue Kooperation der beiden Firmen". 2013-01-15
John Wiley & Sons, Inc.. (1/15/13). "Press Release: Wiley Acquires Assets of FIZ Chemie Berlin. Extended and Integrated Portfolio Will Support Development of New Services for Chemists". Hoboken, NJ. 2013-01-15
BASF SE. (1/15/13). "Press Release: BASF Increases Cash Offer for Pronova BioPharma. Cash Offer Increased to NOK 13.50 per Share". Ludwigshafen. 2013-01-15
BIO Deutschland. (1/14/13). "Press Release: The Atmosphere in the Biotech Sector Remains Positive although Expectations Are Lower than Before. The Willingness to invest Has Reached a New High". Berlin. 2013-01-14
Horizon Discovery Ltd.. (1/14/13). "Press Release: Horizon Discovery and Boehringer Ingelheim Enter Oncology Research Service Collaboration. Five Year Collaboration Will Support Boehringer Ingelheim’s Drug Discovery Programs". Cambridge, UK. 2013-01-14
Universität Göttingen. (1/11/13). "Pressemitteilung: Norddeutsches Zentrum für Mikrobielle Genomforschung eröffnet. Sechs Forschungseinrichtungen kooperieren in den Lebenswissenschaften". 2013-01-11
Almsco International. (1/11/13). "Press Release: New Almsco International Website. New GC/TOF-related Website Offers Analytical Chemists a Wealth of Information". Llantrisant. 2013-01-11
TÜV Süd AG. (1/11/13). "Press Release: TÜV Süd Acquires Food Laboratory in Italy". 2013-01-11
Bavarian Nordic A/S. (1/11/13). "Press Release: Bavarian Nordic Consolidates Its Vaccine Manufacturing in Denmark". Kvistgaard. 2013-01-11
Bayer AG. (1/10/13). "Press Release: Bayer Receives Approval for New Long-term Contraceptive Skyla in the U.S.. New Low Dose Levonorgestrel-releasing Intrauterine System (IUS) – Longterm Contraception for Up to Three Years [Not intended for U.S. and UK m 2013-01-10
Proteo Biotech AG. (1/10/13). "Press Release: FDA Grants Proteo Orphan Drug Designation to Elafin for the Treatment of Pulmonary Arterial Hypertension". Irvine, CA & Kiel. 2013-01-10
Evotec AG. (1/9/13). "Press Release: Evotec and Yale University Form Open Innovation Alliance". Hamburg. 2013-01-09
SIRS-Lab GmbH / Leonhardt Rechtsanwälkte Insolvenzverwalter Notare. (1/9/13). "Press Release: Investor Search for Molecular Diagnostics Company Started. Diagnostics Company SIRS-Lab Insolvent". Jena. 2013-01-09
Biotest AG. (1/9/13). "Press Release: Biotest AG’s Supervisory Board Extends the Term of CEO Prof. Schulz and Appoints Dr. Floß to the Board of Management". Dreieich. 2013-01-09
Biomax Informatics AG. (1/9/13). "Press Release: Biomax Informatics Provides Knowledge Management and Semantic Software Technology, with European STATegra Project, Enabling Integrated Biological Systems Analysis". Planegg. 2013-01-09
Debiopharm S.A.. (1/9/13). "Press Release: Spinomix Closes a $ 3 Million Financing Round Led by Debiopharm Group". Lausanne. 2013-01-09
4SC AG. (1/8/13). "Press Release: 4SC Obtains Key Patent for Anti-cancer Compound Resminostat in Europe". Planegg-Martinsried. 2013-01-08
Lonza Group Ltd.. (1/8/13). "Press Release: Lonza to Expand Antibody Drug Conjugate (ADC) Manufacturing Capacity to Meet Growing Customer Demand". Basel. 2013-01-08
CLC bio A/S. (1/8/13). "Press Release: J. Craig Venter Institute Extends CLC bio Site License through 2017". Aarhus. 2013-01-08
Bayer AG. (1/8/13). "Press Release: Bayer CropScience Acquires Germany-based Biocontrol Company Prophyta GmbH". Monheim. 2013-01-08
Debiopharm S.A.. (1/8/13). "Press Release: Chugai and Debiopharm Group Announce an Exclusive License Agreement for Anti-cancer Agent FF284 (Debio 1347)". Lausanne & Tokyo. 2013-01-08
Formycon AG. (1/8/13). "Press Release: Formycon AG Begins Development of First Biosimilar Drug". Munich. 2013-01-08
Miltenyi Biotec GmbH. (1/7/13). "Press Release: Miltenyi Biotec Distributes and Supports FlowJo 10 Software in Europe". Bergisch Gladbach. 2013-01-07
Cell Signaling Technology, Inc.. (1/7/13). "Press Release: Cell Signaling Technology Granted Patent for PCR Methods for Detection of a Subset of Treatable Non-small Cell Lung Cancers". Danvers, MA. 2013-01-07
Ethris GmbH. (1/7/13). "Press Release: Ethris Announces Research Based Alliance on SNIM Modified RNA with Shire". Munich. 2013-01-07
Evotec AG. (1/7/13). "Press Release: Evotec Expands Collaboration with MedImmune, Receives Milestone Payment". Hamburg. 2013-01-07
High-Tech Gründerfonds Management GmbH. (1/7/13). "Press Release: Drug Response Dx Concludes First Round of Financing with Support from Qiagen and High-Tech Gründerfonds". Hennigsdorf, Bonn & Hilden. 2013-01-07
Priaxon AG. (1/7/13). "Press Release: Priaxon Enters Collaboration with GSK on Protein-Protein-Interactions". Munich. 2013-01-07
Qiagen N.V.. (1/7/13). "Press Release: Qiagen Adds to Pipeline of Personalized Healthcare Diagnostics through Agreements for Promising New Biomarkers". Hilden & Germantown, MD. 2013-01-07
Epizyme, Inc.. (1/7/13). "Press Release: Epizyme, Eisai and Roche to Develop EZH2 Companion Diagnostic. Collaboration Focused on Genetically Defined Lymphomas". Cambridge, MA. 2013-01-07
Addex Therapeutics S.A.. (1/7/13). "Press Release: Addex Announces Positive Data with ADX71441 in a Pre-clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease". Geneva. 2013-01-07
Bayer AG. (1/7/13). "Press Release: Bayer Submits VEGF Trap-eye (aflibercept) for Treatment of Macular Edema Following Central Retinal Vein Occlusion in Japan". Berlin. 2013-01-07
Boehringer Ingelheim. (1/7/13). "Press Release: Boehringer Ingelheim and Eli Lilly and Company Announce Positive Top-line Pivotal Phase III Data Results for Empagliflozin [Ex US & UK Medical Media Only]". Ingelheim. 2013-01-07
Boehringer Ingelheim. (1/7/13). "Press Release: Lilly Reassumes Sole Worldwide Development and Commercialization Rights for Novel Basal Insulin Analog. Announces It Will Begin Remainder of Pre-planned Clinical Trials for LY2605541". Indianapolis, IN & In 2013-01-07
Bayer AG. (1/4/13). "Press Release: Bayer HealthCare Completes Acquisition of Teva’s U.S. Animal Health Business [Not intended for U.S. media]". Leverkusen. 2013-01-04
Bruker Corporation. (1/3/13). "Press Release: Bruker and Erasmus Medical Center Sign an Exclusive Licensing Agreement for Adding Rapid Beta-Lactamase Testing Capabilities to the MALDI Biotyper System". Bremen. 2013-01-03
Cevec Pharmaceuticals GmbH. (1/3/13). "Press Release: Cevec Pharmaceuticals and Vakzine Projekt Management Sign Exclusive License Agreement on the Clinical Development of a Novel Human Cytomegalovirus (CMV) Vaccine". Cologne. 2013-01-03
Evotec AG. (1/3/13). "Press Release: Evotec Acquires Cell Culture Service GmbH. Strenghtens Cell-based Screening and Reagent Platform at Evotec’s Hamburg Site". Hamburg. 2013-01-03
Pfizer Inc.. (1/3/13). "Press Release: EMD Serono and Pfizer Announce FDA Approval of Rebif Rebidose (interferon beta-1a). The Majority of Patients Found Rebif Rebidose Easy to Use in a User Trial". Rockland, MA & New York, NY. 2013-01-03
Zellkraftwerk. (1/3/13). "Press Release: Zellkraftwerk Announces Early Access Program. Select Drug Developers to Obtain Pre-release Access to Groundbreaking Cellular Biomarker Discovery Platform". Hannover. 2013-01-03
Bayer AG. (1/3/13). "Press Release: Phase III DECISION Trial of Nexavar (sorafenib) Meets Primary Endpoint of Improving Progression-free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer [Not intended for U.S. and UK m 2013-01-03
Miltenyi Biotec GmbH. (1/3/13). "Press Release: Nordic Working – the New Miltenyi Biotec Team in Lund, Sweden". Bergisch Gladbach. 2013-01-03
Evotec AG. (1/2/13). "Press Release: Evotec and Apeiron Biologics Announce Collaboration on Cancer Immunotherapy". Hamburg. 2013-01-02
Sphingotec GmbH. (1/2/13). "Press Release: Sphingotec Announces Launch of Blood Test for Breast Cancer Prediciton. Proneurotensin (pro-NT) Is a Unique Biomarker for Breast Cancer Prediction in Women". Hennigsdorf. 2013-01-02
Abbott. (1/2/13). "Press Release: Abbott Completes Separation of Research-based Pharmaceuticals Business". Abbott Park, IL. 2013-01-02
Lonza Group Ltd.. (12/28/12). "Press Release: Lonza Completes the Divestiture of Its Brandenburg, KY Performance Urethanes and Organics Business to Monument Chemical". Basel & Indianapolis, IN. 2012-12-28
Epigenomics AG. (12/21/12). "Press Release: Epigenomics AG. Notice of Loss Pursuant to § 92 par. 1 AktG (Ad hoc release) [Not for distribution in the United States]". Berlin. 2012-12-21
Novartis AG. (12/21/12). "Press Release: Novartis Drug Exjade Approved by European Commission for Iron Overload in Patients with Non-transfusion-dependent Thalassemia". Basel. 2012-12-21
Octpaharma AG. (12/21/12). "Press Release: Octapharma Wins Major Tender Victory in Norway". Lachen. 2012-12-21
Sanochemia Pharmazeutika AG. (12/21/12). "Pressemitteilung: Vorläufige Zahlen für das Geschäftsjahr 2011/12". Wien. 2012-12-21
Sanochemia Pharmazeutika AG. (12/21/12). "Pressemitteilung: Änderungen in der Geschäftsführung der Sanochemia Pharmazeutika AG". Wien. 2012-12-21
Cevec Pharmaceuticals GmbH. (12/20/12). "Press Release: Cevec Pharmaceuticals Signs License Agreement with Yuhan Corporation". Cologne. 2012-12-20
Biotest AG. (12/20/12). "Press Release: FDA Approves Biotest’s Bivigam, an Intravenous Immune Globulin (Human), 10% Liquid". Dreieich & Baco Raton, FL. 2012-12-20
Epigenomics AG. (12/20/12). "Press Release: Epigenomics AG Provides Update on Financing Plan [Not for distribution in the United States]". Berlin & Seattle, WA. 2012-12-20
Galenica Holding AG. (12/20/12). "Press Release: PA21 Dossier Sent for Submission to EMA to Seek Approval in the EU". 2012-12-20
Sygnis Pharma AG. (12/20/12). "Press Release: Sygnis Announces the Adaptation of Its Organisation to the New Business Activity". Heidelberg. 2012-12-20
Addex Therapeutics S.A.. (12/20/12). "Press Release: Addex Scientists Discover and Characterize the First Potent and Selective Small Molecule Negative Allosteric Modulator Targeting mGlu7 Receptor". Geneva. 2012-12-20
Evolva Holding S.A.. (12/20/12). "Press Release: Evolva Successfully Discussed Clinical Development Plans for EV-077 in Diabetes Patients with German Regulatory Authority". Reinach. 2012-12-20
Epigenomics AG. (12/19/12). "Press Release: Epigenomics Provides Additional Data of Its Head-to-Head Comparison Study of Epi proColon to FIT". Berlin & Seattle, WA. 2012-12-19
Intercell AG. (12/19/12). "Press Release: Intercell Receives CHMP Positive Opinion for the Pediatric Indication of Its Japanese Encephalitis Vaccine in Europe". Vienna. 2012-12-19
Lonza Group Ltd.. (12/19/12). "Press Release: Lonza and Sartorius Stedim Biotech Enter Collaboration, Supply and Distribution Agreement in the Field of Cell Culture Media". Basel. 2012-12-19
Analytik Jena AG. (12/18/12). "Press Release: Group Figures for the 2011/2012 Financial Year. Analytik Jena Exceeds Forecasts and Confirms Preliminary Figures". Jena. 2012-12-18
Sartorius Stedim Biotech GmbH. (12/18/12). "Press Release: Sartorius Stedim Biotech Expands PAT Software Portfolio for Optimization of Biopharmaceutical Development and Manufacturing Processes". Göttingen. 2012-12-18
next pagenext page 1 2 3 ... 62 63 64 ... 97 98 99  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [LSUS] – The Business Web Portal 600x60px

» top